Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits?

References

• Cox W H. An indication for the use of imipramine in attention deficit disorder. American Journal of Psychiatry 1982; 139: 1058–1060
   Google Scholar
• Anderson J C, Williams S, McGee R, Silva P A. DSM-III disorders in pre-adolescent children. Archives of General Psychiatry 1987; 44: 69–76
   PubMed Web of Science ®Google Scholar
• Lahey B B, Schaughency E A, Hynd G W, Carlson C L, Nieves N. Attention deficit disorder with and without hyperactivity: comparison of behavioural characteristics of clinic-referred children. Journal of the American Academy of Child and Adolescent Psychiatry 1987; 26: 718–723
   PubMed Web of Science ®Google Scholar
• Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry 1991; 148: 564–577
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone S V, Keenan K, Steingard R, Tsuang M T. Familial association between attention deficit disorder (ADD) and anxiety disorder. American Journal of Psychiatry 1991; 148: 251–256
   PubMed Web of Science ®Google Scholar
• Plizka S R. Comorbidity of attention deficit hyperactivity disorder and overanxious disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31: 197–203
   PubMed Web of Science ®Google Scholar
• Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 886–896
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone S V, Milberger S, et al. A prospective 4 year follow up study of attention deficit hyperactivity and related disorders. Archives of General Psychiatry 1996; 53: 437–446
   PubMed Web of Science ®Google Scholar
• Jensen P S, Martin D, Cantwell D P. Comorbidity in ADHD: implications for research, practice, and DSM-V. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 1065–1079
   PubMed Web of Science ®Google Scholar
• Hill J C, Schoener E P. Age dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry 1996; 153: 1143–1146
   PubMed Web of Science ®Google Scholar
• Luk S L. Cross-cultural aspects. Hyperactivity disorders of childhood; Cambridge monographs in child and adolescent psychiatry, S Sandberg. Cambridge University Press, Cambridge 1996; 350–381
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. American Psychiatric Association Press, Washington, DC 1987
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association Press, Washington, DC 1994
   Google Scholar
• Plizka S R. Effect of anxiety on cognition, behaviour and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1989; 28: 882–887
   PubMedGoogle Scholar
• Plizka S R, Maas J W, Javors M A, Rogeness G A. Urinary catecholamines in attention deficit hyperactivity disorder with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33: 1165–1173
   PubMed Web of Science ®Google Scholar
• Reynolds C R, Richmond B O. Revised Children's Manifest Anxiety Scale: manual. Western Psychological Services, Los Angeles, CA 1985
   Google Scholar
• Last C G, Hersen M, Kazdin A, Orvaschel H, Perrin S. Anxiety disorders in children and their families. Archives of General Psychiatry 1991; 48: 928–934
   PubMed Web of Science ®Google Scholar
• Puig-Antich J, Chambers W. Schedule for affective disorders and schizophrenia for school aged children. State Psychiatric Institute, New York 1978, Unpublished interview schedule.
   Google Scholar
• Biederman J, Faraone S V, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of co-morbidity in probands and relatives in psychiatrically and paediatrically referred samples. Archives of General Psychiatry 1992; 49: 728–738
   PubMed Web of Science ®Google Scholar
• Orvaschel H, Puig-Antich J. Schedule for affective disorders and schizophrenia for school aged children: epidemiological. 4th version. Nova University Center for Psychological Study, Fort Lauderdale, FL 1987
   Google Scholar
• Buitelaar Jan K, Van-der-Gaag R J, Swaab-Barneveld H, Kuiper M. The prediction of clinical response to methylphenidate in children with attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 1025–1032
   PubMed Web of Science ®Google Scholar
• Goyette C H, Conners C K, Ulrich R F. Normative data on revised Conners Parent and Teacher Rating Scales. Journal of Abnormal Child Psychology 1978; 6: 221–236
   PubMed Web of Science ®Google Scholar
• Pelham W E, Atkins M, Murphy H A. ADD with and without hyperactivity: parent, teacher and peer rating correlates. DSM-III category of attention deficit disorder: rationale, operation and correlates (Symposium), W E Pelham. American Psychological Association, Los Angeles 1981
   Google Scholar
• Rutter M, Tizard J, Whitmore K. Education, health and behaviour: psychological and medical study of child development. Wiley, New York 1970
   Google Scholar
• Spielberger C. Manual for the State-Trait Anxiety Inventory for Children. Consulting Psychologists Press, Palo Alto, CA 1973
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 2nd ed. American Psychiatric Association Press, Washington, DC 1968
   Google Scholar
• Zahn T P, Abate F, Little B C, Wender P H. Minimal brain dysfunction, stimulant drugs and autonomic nervous system activity. Archives of General Psychiatry 1975; 32: 381–387
   PubMed Web of Science ®Google Scholar
• Swanson J M, Kinsbourne M, Roberts W, Zucker K. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Paediatrics 1978; 61: 21–29
   PubMed Web of Science ®Google Scholar
• Taylor E, Schachar R, Thorley G, Wieselberg H M, Everitt B, Rutter M. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine 1987; 17: 121–143
   PubMed Web of Science ®Google Scholar
• Taylor E, Schachar R, Thorley G, Wieselberg M. Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients. British Journal of Psychiatry 1986; 149: 760–777
   PubMed Web of Science ®Google Scholar
• Taylor E, Everitt B, Schachar R, Thorley G, Rutter M, Wieselberg M. Conduct disorder and hyperactivity: II. A cluster analytic approach to the identification of a behavioural syndrome. British Journal of Psychiatry 1986; 149: 760–777
   PubMed Web of Science ®Google Scholar
• Brown C S. Treatment of attention deficit hyperactivity disorder: a critical review. Drug Intelligence and Clinical Pharmacology 1991; 25: 1207–1213
   Google Scholar
• Simeon J G, Knott V J, Dubois C, et al. Buspirone therapy of mixed anxiety disorders in childhood and adolescence: a pilot study. Journal of Child and Adolescent Psychopharmacology 1994; 4: 159–170
   Web of Science ®Google Scholar
• Plizka S R. Tricyclic antidepressants in the treatment of children with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1987; 26: 127–132
   PubMedGoogle Scholar
• Biederman J. Attention deficit hyperactivity disorder. Annals of Clinical Psychiatry 1990; 3: 9–22
   Google Scholar
• Biederman J. The diagnosis and treatment of adolescent anxiety disorders. Massachusetts General Hospital Clinical Psychopharmacology Unit Educational Symposium. High-potency benzodiazepines: emerging uses in psychiatry. Journal of Clinical Psychiatry 1990; 51((Suppl.))20–26
   PubMedGoogle Scholar
• Wilens T E, Spencer T, Biederman J, Wozianek J. Combined pharmacotherapy: an emerging trend in paediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 110–112
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. American Psychiatric Association Press, Washington, DC 1980
   Google Scholar
• Urman R, Ickowicz A, Fulford P, Tannock R. An exaggerated cardiovascular response to methylphenidate in ADHD children with anxiety. Journal of Child and Adolescent Psychopharmacology 1995; 5: 29–37
   Web of Science ®Google Scholar
• Taylor E, Sandberg S, Thorley G, Giles S. The epidemiology of childhood hyperactivity. Institute of Psychiatry Maudsley monograph. Oxford University Press, London 1991
   Google Scholar
• Shaffer D, Schonfeld I, O'Connor P, et al. Neurological soft signs: their relationship to psychiatric disorder and intelligence in childhood and adolescence. Archives of General Psychiatry 1985; 42: 342–351
   PubMed Web of Science ®Google Scholar
• Niswander K R, Gordon M. The women and their pregnancies: the collaborative perinatal study of the National Institute of Neurological Diseases and Stroke. US Government Printing Office, Washington, DC 1972, DHEW Publication No. (NIH) 73–379
   Google Scholar